Growth Differentiation Factor-15 (GDF-15) is a Biological Marker in Heart Failure

نویسندگان

چکیده

Heart failure is an important medical, social and economic problem around the world. In recent years, a number of diagnostic prognostic biological markers blood in cardiovascular diseases have been studied. Identification new markers, analysis their pathophysiological aspects changes concentration under influence various treatment options, allow us to understand many pathogenetic features development course heart failure. decades, natriuretic peptides introduced into clinical practice, which are widely used as reliable for assessment. Growth differentiation factor-15 cytokine belonging family transforming growth factors, activity significantly increased stress inflammation. patients with chronic failure, this marker associated risk overall mortality adverse events; preserved left ventricular ejection fraction, use showed significance. Data from Framingham Study that was only multivariate statistically significant association all events. Eight studies overexpression It shown acute not inferior brain peptide precursor. To confirm value it necessary conduct extensive prospective randomized trials.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

GDF 15 ( growth differentiation factor 15 )

The premature GDF/PDF/MIC-1 protein consists of 308 amino acids that contain a 29 amino acid signal peptide, a 167 amino acid propeptide, and a 112 amino acid mature protein. The mature protein is secreted as a homodimer linked by disulfide bonds and is released from the propeptide following intracellular cleavage at RXXR furine-like cleavage site. The mature peptide of GDF-1/MIC-1 contains two...

متن کامل

Growth-Differentiation Factor-15 as Additional Prognostic Biomarkers in Heart Failure

Heart Failure (HF) remains to be a leading factor of cardiovascular morbidity and mortality. Although risk stratification of HF is promising prediction care, there are several controversies regarding choosing more optimal combinations of biomarkers and method (single versus serial measurements) of biomarker use in routine clinical practice. Growth differentiation factor-15 (GDF-15) is considere...

متن کامل

The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction

AIMS Heart failure with normal ejection fraction (HFnEF) is an important clinical entity that remains incompletely understood. The novel biomarker growth differentiation factor 15 (GDF-15) is elevated in systolic heart failure (HFrEF) and is predictive of an adverse outcome. We investigated the clinical relevance of GDF-15 plasma levels in HFnEF. METHODS AND RESULTS A subgroup of patients fro...

متن کامل

Growth differentiation factor-15 (GDF-15), novel biomarker for assessing atrial fibrosis in patients with atrial fibrillation and rheumatic heart disease.

OBJECTIVE Growth differentiation factor-15 (GDF-15) has been identified as a strong biomarker of cardiovascular diseases; however, no evidence are available concerning the relationship of GDF-15 and atrial fibrosis in patients with atrial fibrillation (AF) and rheumatic heart disease (RHD). METHODS Twenty patients with rheumatic heart disease were divided into two groups, 10 cases with AF and...

متن کامل

Growth differentiation factor 15: a canary in a coal mine?

It has been 50 years since Dr. William B. Kannel coined the term “factors of risk” in relation to cardiovascular disease (1). Since then, clinical risk assessment, including the use of circulating biomarkers, has become an integral part of medical practice. The current era of genomics, proteomics, and metabolomics is projected to lead to the discovery of an immense number of novel candidate bio...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Arhiv? vnutrennej mediciny

سال: 2023

ISSN: ['2226-6704', '2411-6564']

DOI: https://doi.org/10.20514/2226-6704-2023-13-1-14-23